Overview Evaluate Long-Term Safety and Efficacy WC3011 Status: Completed Trial end date: 2012-12-01 Target enrollment: Participant gender: Summary This is an open-label extension study evaluating the long-term safety and efficacy of WC3011 in non-hysterectomized, healthy, postmenopausal women with vulvovaginal atrophy. Phase: Phase 3 Details Lead Sponsor: Warner ChilcottTreatments: EstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valeratePolyestradiol phosphate